 | • レポートコード：QAF27783 • 出版社/出版日：QYResearch / 2021年4月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の代謝作用薬品市場について種類別（グリコーゲン代謝疾患治療薬、脂質代謝疾患治療薬、アミノ酸代謝治療薬、その他）、用途別（病院、小売薬局）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・代謝作用薬品市場の概要 ・世界の主要地域別代謝作用薬品市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の代謝作用薬品市場規模2016-2021：種類別（グリコーゲン代謝疾患治療薬、脂質代謝疾患治療薬、アミノ酸代謝治療薬、その他） ・世界の代謝作用薬品市場予測2012-2027：種類別（グリコーゲン代謝疾患治療薬、脂質代謝疾患治療薬、アミノ酸代謝治療薬、その他） ・世界の代謝作用薬品市場規模2016-2021：用途別（病院、小売薬局） ・世界の代謝作用薬品市場予測2012-2027：用途別（病院、小売薬局） ・代謝作用薬品のアメリカ市場規模と予測2016-2021 ・代謝作用薬品のヨーロッパ市場規模と予測2016-2021 ・代謝作用薬品の中国市場規模と予測2016-2021 ・代謝作用薬品の日本市場規模と予測2016-2021 ・代謝作用薬品の東南アジア市場規模と予測2016-2021 ・代謝作用薬品のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Bioray、Spritual River、Natures Way Elite, LLC、Acupeds、Thermo Fisher Scientific Inc） ・代謝作用薬品の製造コスト分析 ・販売チャネル、流通業者、顧客 ・代謝作用薬品の市場動向・機会・課題 ・調査の結論 |
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc.
USA is the largest supplier of Metabolism Drugs, with production revenue market share over 43%, while the sales market share is 40% in 2015.
Europe, following USA, takes production revenue market share of 35% and the sales market share over 23%. That is to say, there are a large number of exports in Europe. Japan is an important market of Drugs for Metabolism Drugs in Asia, accounting for 9% production revenue market share and 10% sales revenue market share of global market.
Players with high-quality products are Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Beohrigher Ingelheim. Sometimes they merger other competitors, through that they can promote their position in global Metabolism Drugs market.
Market Analysis and Insights: Global Metabolism Drugs Market
The global Metabolism Drugs market was valued at US$ 16200 in 2020 and will reach US$ 22080 million by the end of 2027, growing at a CAGR of 5.3% during 2022-2027.
Global Metabolism Drugs Scope and Market Size
The global Metabolism Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metabolism Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Glycogen Metabolism Disease Drug
Lipid Metabolism Disease Drug
Amino Acid Metabolism Drug
Other
Segment by Application
Hospital
Retail Pharmacy
The Metabolism Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Metabolism Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Bioray
Spritual River
Natures Way Elite, LLC
Acupeds
Thermo Fisher Scientific Inc
1 Metabolism Drugs Market Overview
1.1 Metabolism Drugs Product Scope
1.2 Metabolism Drugs Segment by Type
1.2.1 Global Metabolism Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Glycogen Metabolism Disease Drug
1.2.3 Lipid Metabolism Disease Drug
1.2.4 Amino Acid Metabolism Drug
1.2.5 Other
1.3 Metabolism Drugs Segment by Application
1.3.1 Global Metabolism Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Metabolism Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Metabolism Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Metabolism Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Metabolism Drugs Price Trends (2016-2027)
2 Metabolism Drugs Estimates and Forecasts by Region
2.1 Global Metabolism Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Metabolism Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Metabolism Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Metabolism Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Metabolism Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Metabolism Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Metabolism Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Metabolism Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Metabolism Drugs Estimates and Projections (2016-2027)
2.4.3 China Metabolism Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Metabolism Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Metabolism Drugs Estimates and Projections (2016-2027)
2.4.6 India Metabolism Drugs Estimates and Projections (2016-2027)
3 Global Metabolism Drugs Competition Landscape by Players
3.1 Global Top Metabolism Drugs Players by Sales (2016-2021)
3.2 Global Top Metabolism Drugs Players by Revenue (2016-2021)
3.3 Global Metabolism Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Metabolism Drugs as of 2020)
3.4 Global Metabolism Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Metabolism Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Metabolism Drugs Market Size by Type
4.1 Global Metabolism Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Metabolism Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Metabolism Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Metabolism Drugs Price by Type (2016-2021)
4.2 Global Metabolism Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Metabolism Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Metabolism Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Metabolism Drugs Price Forecast by Type (2022-2027)
5 Global Metabolism Drugs Market Size by Application
5.1 Global Metabolism Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Metabolism Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Metabolism Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Metabolism Drugs Price by Application (2016-2021)
5.2 Global Metabolism Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Metabolism Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Metabolism Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Metabolism Drugs Price Forecast by Application (2022-2027)
6 North America Metabolism Drugs Market Facts & Figures
6.1 North America Metabolism Drugs Sales by Company
6.1.1 North America Metabolism Drugs Sales by Company (2016-2021)
6.1.2 North America Metabolism Drugs Revenue by Company (2016-2021)
6.2 North America Metabolism Drugs Sales Breakdown by Type
6.2.1 North America Metabolism Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Metabolism Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Metabolism Drugs Sales Breakdown by Application
6.3.1 North America Metabolism Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Metabolism Drugs Sales Breakdown by Application (2022-2027)
7 Europe Metabolism Drugs Market Facts & Figures
7.1 Europe Metabolism Drugs Sales by Company
7.1.1 Europe Metabolism Drugs Sales by Company (2016-2021)
7.1.2 Europe Metabolism Drugs Revenue by Company (2016-2021)
7.2 Europe Metabolism Drugs Sales Breakdown by Type
7.2.1 Europe Metabolism Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Metabolism Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Metabolism Drugs Sales Breakdown by Application
7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)
8 China Metabolism Drugs Market Facts & Figures
8.1 China Metabolism Drugs Sales by Company
8.1.1 China Metabolism Drugs Sales by Company (2016-2021)
8.1.2 China Metabolism Drugs Revenue by Company (2016-2021)
8.2 China Metabolism Drugs Sales Breakdown by Type
8.2.1 China Metabolism Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Metabolism Drugs Sales Breakdown by Type (2022-2027)
8.3 China Metabolism Drugs Sales Breakdown by Application
8.3.1 China 243 Sales Breakdown by Application (2016-2021)
8.3.2 China 243 Sales Breakdown by Application (2022-2027)
9 Japan Metabolism Drugs Market Facts & Figures
9.1 Japan Metabolism Drugs Sales by Company
9.1.1 Japan Metabolism Drugs Sales by Company (2016-2021)
9.1.2 Japan Metabolism Drugs Revenue by Company (2016-2021)
9.2 Japan Metabolism Drugs Sales Breakdown by Type
9.2.1 Japan Metabolism Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Metabolism Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Metabolism Drugs Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Metabolism Drugs Market Facts & Figures
10.1 Southeast Asia Metabolism Drugs Sales by Company
10.1.1 Southeast Asia Metabolism Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Metabolism Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Metabolism Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Metabolism Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Metabolism Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Metabolism Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Metabolism Drugs Market Facts & Figures
11.1 India Metabolism Drugs Sales by Company
11.1.1 India Metabolism Drugs Sales by Company (2016-2021)
11.1.2 India Metabolism Drugs Revenue by Company (2016-2021)
11.2 India Metabolism Drugs Sales Breakdown by Type
11.2.1 India Metabolism Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Metabolism Drugs Sales Breakdown by Type (2022-2027)
11.3 India Metabolism Drugs Sales Breakdown by Application
11.3.1 India Metabolism Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Metabolism Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Metabolism Drugs Business
12.1 Bioray
12.1.1 Bioray Corporation Information
12.1.2 Bioray Business Overview
12.1.3 Bioray Metabolism Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bioray Metabolism Drugs Products Offered
12.1.5 Bioray Recent Development
12.2 Spritual River
12.2.1 Spritual River Corporation Information
12.2.2 Spritual River Business Overview
12.2.3 Spritual River Metabolism Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Spritual River Metabolism Drugs Products Offered
12.2.5 Spritual River Recent Development
12.3 Natures Way Elite, LLC
12.3.1 Natures Way Elite, LLC Corporation Information
12.3.2 Natures Way Elite, LLC Business Overview
12.3.3 Natures Way Elite, LLC Metabolism Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Natures Way Elite, LLC Metabolism Drugs Products Offered
12.3.5 Natures Way Elite, LLC Recent Development
12.4 Acupeds
12.4.1 Acupeds Corporation Information
12.4.2 Acupeds Business Overview
12.4.3 Acupeds Metabolism Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Acupeds Metabolism Drugs Products Offered
12.4.5 Acupeds Recent Development
12.5 Thermo Fisher Scientific Inc
12.5.1 Thermo Fisher Scientific Inc Corporation Information
12.5.2 Thermo Fisher Scientific Inc Business Overview
12.5.3 Thermo Fisher Scientific Inc Metabolism Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Thermo Fisher Scientific Inc Metabolism Drugs Products Offered
12.5.5 Thermo Fisher Scientific Inc Recent Development
…
13 Metabolism Drugs Manufacturing Cost Analysis
13.1 Metabolism Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Metabolism Drugs
13.4 Metabolism Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Metabolism Drugs Distributors List
14.3 Metabolism Drugs Customers
15 Market Dynamics
15.1 Metabolism Drugs Market Trends
15.2 Metabolism Drugs Drivers
15.3 Metabolism Drugs Market Challenges
15.4 Metabolism Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Metabolism Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Metabolism Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Metabolism Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Metabolism Drugs Sales (K Units) by Region (2016-2021)
Table 5. Global Metabolism Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Metabolism Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Metabolism Drugs Revenue Share by Region (2016-2021)
Table 8. Global Metabolism Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Metabolism Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Metabolism Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Metabolism Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Metabolism Drugs Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Metabolism Drugs Sales Share by Company (2016-2021)
Table 14. Global Metabolism Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Metabolism Drugs Revenue Share by Company (2016-2021)
Table 16. Global Metabolism Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolism Drugs as of 2020)
Table 17. Global Metabolism Drugs Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Metabolism Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Metabolism Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Metabolism Drugs Sales (K Units) by Type (2016-2021)
Table 22. Global Metabolism Drugs Sales Share by Type (2016-2021)
Table 23. Global Metabolism Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Metabolism Drugs Price (USD/Unit) by Type (2016-2021)
Table 25. Global Metabolism Drugs Sales Share by Type (2022-2027)
Table 26. Global Metabolism Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Metabolism Drugs Revenue Share by Type (2022-2027)
Table 28. Global Metabolism Drugs Price (USD/Unit) by Type (2022-2027)
Table 29. Global Metabolism Drugs Sales (K Units) by Application (2016-2021)
Table 30. Global Metabolism Drugs Sales Share by Application (2016-2021)
Table 31. Global Metabolism Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Metabolism Drugs Price (USD/Unit) by Application (2016-2021)
Table 33. Global Metabolism Drugs Sales (K Units) by Application (2022-2027)
Table 34. Global Metabolism Drugs Sales Share by Application (2022-2027)
Table 35. Global Metabolism Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Metabolism Drugs Revenue Share by Application (2022-2027)
Table 37. Global Metabolism Drugs Price (USD/Unit) by Application (2022-2027)
Table 38. North America Metabolism Drugs Sales (K Units) by Company (2016-2021)
Table 39. North America Metabolism Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Metabolism Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Metabolism Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Metabolism Drugs Sales by Type (2016-2021) & (K Units)
Table 43. North America Metabolism Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Metabolism Drugs Sales by Type (2022-2027) & (K Units)
Table 45. North America Metabolism Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Metabolism Drugs Sales by Application (2016-2021) & (K Units)
Table 47. North America Metabolism Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Metabolism Drugs Sales by Application (2022-2027) & (K Units)
Table 49. North America Metabolism Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Metabolism Drugs Sales (K Units) by Company (2016-2021)
Table 51. Europe Metabolism Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Metabolism Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Metabolism Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Metabolism Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Metabolism Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Metabolism Drugs Sales by Type (2022-2027) & (K Units)
Table 57. Europe Metabolism Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Metabolism Drugs Sales by Application (2016-2021) & (K Units)
Table 59. Europe Metabolism Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Metabolism Drugs Sales by Application (2022-2027) & (K Units)
Table 61. Europe Metabolism Drugs Sales Market Share by Application (2022-2027)
Table 62. China Metabolism Drugs Sales (K Units) by Company (2016-2021)
Table 63. China Metabolism Drugs Sales Market Share by Company (2016-2021)
Table 64. China Metabolism Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Metabolism Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Metabolism Drugs Sales by Type (2016-2021) & (K Units)
Table 67. China Metabolism Drugs Sales Market Share by Type (2016-2021)
Table 68. China Metabolism Drugs Sales by Type (2022-2027) & (K Units)
Table 69. China Metabolism Drugs Sales Market Share by Type (2022-2027)
Table 70. China Metabolism Drugs Sales by Application (2016-2021) & (K Units)
Table 71. China Metabolism Drugs Sales Market Share by Application (2016-2021)
Table 72. China Metabolism Drugs Sales by Application (2022-2027) & (K Units)
Table 73. China Metabolism Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Metabolism Drugs Sales (K Units) by Company (2016-2021)
Table 75. Japan Metabolism Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Metabolism Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Metabolism Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Metabolism Drugs Sales by Type (2016-2021) & (K Units)
Table 79. Japan Metabolism Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Metabolism Drugs Sales by Type (2022-2027) & (K Units)
Table 81. Japan Metabolism Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Metabolism Drugs Sales by Application (2016-2021) & (K Units)
Table 83. Japan Metabolism Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Metabolism Drugs Sales by Application (2022-2027) & (K Units)
Table 85. Japan Metabolism Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Metabolism Drugs Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Metabolism Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Metabolism Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Metabolism Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Metabolism Drugs Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Metabolism Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Metabolism Drugs Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Metabolism Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Metabolism Drugs Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Metabolism Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Metabolism Drugs Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Metabolism Drugs Sales Market Share by Application (2022-2027)
Table 98. India Metabolism Drugs Sales (K Units) by Company (2016-2021)
Table 99. India Metabolism Drugs Sales Market Share by Company (2016-2021)
Table 100. India Metabolism Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Metabolism Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Metabolism Drugs Sales by Type (2016-2021) & (K Units)
Table 103. India Metabolism Drugs Sales Market Share by Type (2016-2021)
Table 104. India Metabolism Drugs Sales by Type (2022-2027) & (K Units)
Table 105. India Metabolism Drugs Sales Market Share by Type (2022-2027)
Table 106. India Metabolism Drugs Sales by Application (2016-2021) & (K Units)
Table 107. India Metabolism Drugs Sales Market Share by Application (2016-2021)
Table 108. India Metabolism Drugs Sales by Application (2022-2027) & (K Units)
Table 109. India Metabolism Drugs Sales Market Share by Application (2022-2027)
Table 110. Bioray Corporation Information
Table 111. Bioray Description and Business Overview
Table 112. Bioray Metabolism Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Bioray Metabolism Drugs Product
Table 114. Bioray Recent Development
Table 115. Spritual River Corporation Information
Table 116. Spritual River Description and Business Overview
Table 117. Spritual River Metabolism Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Spritual River Metabolism Drugs Product
Table 119. Spritual River Recent Development
Table 120. Natures Way Elite, LLC Corporation Information
Table 121. Natures Way Elite, LLC Description and Business Overview
Table 122. Natures Way Elite, LLC Metabolism Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Natures Way Elite, LLC Metabolism Drugs Product
Table 124. Natures Way Elite, LLC Recent Development
Table 125. Acupeds Corporation Information
Table 126. Acupeds Description and Business Overview
Table 127. Acupeds Metabolism Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Acupeds Metabolism Drugs Product
Table 129. Acupeds Recent Development
Table 130. Thermo Fisher Scientific Inc Corporation Information
Table 131. Thermo Fisher Scientific Inc Description and Business Overview
Table 132. Thermo Fisher Scientific Inc Metabolism Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Thermo Fisher Scientific Inc Metabolism Drugs Product
Table 134. Thermo Fisher Scientific Inc Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Metabolism Drugs Distributors List
Table 138. Metabolism Drugs Customers List
Table 139. Metabolism Drugs Market Trends
Table 140. Metabolism Drugs Market Drivers
Table 141. Metabolism Drugs Market Challenges
Table 142. Metabolism Drugs Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Metabolism Drugs Product Picture
Figure 2. Global Metabolism Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Metabolism Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Examples
Figure 7. Retail Pharmacy Examples
Figure 8. Global Metabolism Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Metabolism Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Metabolism Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 11. Global Metabolism Drugs Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 12. Global Metabolism Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Metabolism Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Metabolism Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Metabolism Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 16. Europe Metabolism Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Metabolism Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Metabolism Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Metabolism Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Metabolism Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Metabolism Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Metabolism Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Metabolism Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Metabolism Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Metabolism Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Metabolism Drugs Players Market Share by Revenue in Metabolism Drugs: 2016 & 2020
Figure 27. Metabolism Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Metabolism Drugs Revenue Share by Type (2016-2021)
Figure 29. Global Metabolism Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Metabolism Drugs Revenue Share by Application (2016-2021)
Figure 31. Global Metabolism Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Metabolism Drugs Sales Market Share by Type in 2020
Figure 33. North America Metabolism Drugs Sales Market Share by Application in 2020
Figure 34. Europe Metabolism Drugs Sales Market Share by Type in 2020
Figure 35. Europe Metabolism Drugs Sales Market Share by Application in 2020
Figure 36. China Metabolism Drugs Sales Market Share by Type in 2020
Figure 37. China Metabolism Drugs Sales Market Share by Application in 2020
Figure 38. Japan Metabolism Drugs Sales Market Share by Type in 2020
Figure 39. Japan Metabolism Drugs Sales Market Share by Application in 2020
Figure 40. Southeast Asia Metabolism Drugs Sales Market Share by Type in 2020
Figure 41. Southeast Asia Metabolism Drugs Sales Market Share by Application in 2020
Figure 42. India Metabolism Drugs Sales Market Share by Type in 2020
Figure 43. India Metabolism Drugs Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Metabolism Drugs
Figure 46. Manufacturing Process Analysis of Metabolism Drugs
Figure 47. Metabolism Drugs Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
世界のグリコーゲン代謝＆糖原病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market The global Glycogen Metabolism and Glycogen Storage Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With …- 世界のアミノ酸代謝異常症薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Amino Acid Metabolism Disorder Drug Market The global Amino Acid Metabolism Disorder Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…
- 世界のタバコ代謝遺伝子検査市場規模・現状・予測（2021年-2027年） A detection method for cigarette metabolism Market Analysis and Insights: Global Cigarette Metabolism Gene Testing Market The global Cigarette Metabolism Gene Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…
- 世界のアルコール代謝遺伝子検査市場規模・現状・予測（2021年-2027年） A method for testing alcohol metabolism Market Analysis and Insights: Global Alcohol Metabolism Genetic Testing Market The global Alcohol Metabolism Genetic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry…
- 世界の葉酸代謝遺伝子検査市場規模・現状・予測（2021年-2027年） A detection method for folic acid metabolism ability Market Analysis and Insights: Global Folate Metabolism Genetic Testing Market The global Folate Metabolism Genetic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. Wi…